# Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction

> **NCT00430885** · PHASE3 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 62 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Octagam (IVIG)

## Key facts

- **NCT ID:** NCT00430885
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-05
- **Final completion:** 2010-05
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2014-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430885, "Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00430885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*